Qubit pharmaceuticals secures 16.1 million euros in seed round to revolutionize drug discovery
The Quantum Insider - 10-Jun-2022Developing a software platform that uses quantum computers to accelerate the discovery of new drugs
Join the club for FREE to access the whole archive and other member benefits.
Teacher at Penn State University, Science Writer at The Quantum Insider, and Chief Content Officer at Resonance
Matt Swayne has served as a writer, editor and analyst at The Quantum Insider since its inception. He also serves as chief content officer for Resonance. With a several-decades long background in journalism and communications, he has worked as a science communicator for more than 12 years, and is currently working as a teaching professor for Penn State University.
In addition to his service as a science communicator, Matt also develops courses to improve the media and communications skills of scientists and has taught courses.
Visit website: https://www.mattswayne.com/
See alsoDetails last updated 21-Nov-2023
Developing a software platform that uses quantum computers to accelerate the discovery of new drugs